Word

PIVALENT

Status

Dead

Status Code

602

Status Date

Tuesday, October 31, 2023

Serial Number

97605109

Mark Type

4000

Filing Date

Friday, September 23, 2022

Abandoned Date

Monday, October 16, 2023

Trademark Owner History

Pivalent Therapeutics, Inc.

Classifications

5 Pharmaceuticals and medicines for the prevention and treatment of cancer; pharmaceuticals and medicines for the identification and treatment of tumors; pharmaceuticals preparations in the form of capsules, tablets, and powders for the treatment of cancer; intravenous pharmaceuticals, namely, vials for intravenous administration sold filled with preparations for the treatment of cancer; biological preparations for the prevention and treatment of cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in testing and treatment of cancer; medical diagnostic reagents; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations in the nature of drug delivery agents that facilitate administration of other pharmaceutical preparations into the human body for enhanced treatment of cancer

42 Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; testing, inspection, research, or development of pharmaceutical preparations for the prevention and treatment of cancer; research and development of pharmaceuticals and medicines for the identification and treatment of tumors; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the fields of pharmaceutical and biological preparations; development of new technology for others in the fields of pharmaceuticals, biotechnology, and medicine; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, and diagnostics; biological research and analysis; chemical research; medical research, namely, conducting clinical trials for others

Trademark Events

Oct 31, 2023

Abandonment Notice E-Mailed - Failure To Respond

Oct 31, 2023

Abandonment Notice Mailed - Failure To Respond

Oct 31, 2023

Abandonment - Failure To Respond Or Late Response

Jul 13, 2023

Notification Of Non-Final Action E-Mailed

Jul 13, 2023

Non-Final Action E-Mailed

Jul 13, 2023

Non-Final Action Written

Jul 6, 2023

Assigned To Examiner

Oct 11, 2022

New Application Office Supplied Data Entered

Sep 27, 2022

New Application Entered